Browsing: Life Insurance
Longevity and Mortality Investor’s coverage of annuity and life insurance issuance and topics and trends relating to life insurance balance sheet and risk management.
For life settlement markets, earlier diagnosis of chronic diseases may reduce projected life expectancy, thereby influencing the expected duration of premium payments and the timing of policy maturities.
Total US annuity sales were $104.6bn in the first quarter of 2026 according to preliminary results from LIMRA’s U.S. Individual Annuity Sales Survey, which represents 87% of the total US annuity market.
The total number of life insurance policies purchased in the life settlement industry’s secondary market grew 10.2% from 2,697 in 2024 to 2,972 in 2025, according to new data published by life settlement provider, Coventry.
The European Insurance and Occupational Pensions Authority (EIOPA) has turned its head towards the almost zeitgeist topic of ‘private equity’ ownership of…
Total new annualised premium tops a record-breaking $17.5bn in 2025.
Fitch Ratings has a ‘neutral’ outlook for North American life insurers for 2026 despite a more challenging backdrop.
New policies that will fuel future trades in the life settlement market continue to be issued in healthy volumes, but in real terms, are slowly contracting.
In today’s rapidly evolving insurance landscape, the arrival of AI in Life and Health underwriting and claims workflows is no longer a distant possibility – it’s already a reality.
Griffith Ballard will continue to operate from Cedar Rapids under its existing leadership team.
All in all, as counterparties for longevity and mortality risk investors, US life insurers remain strong.